Orion Market Research
European Healthcare CDMO Market, Size, Share,
Analysis Report & Forecast to 2026
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
The European healthcare CDMO market is projected to grow at a significant CAGR during the
forecast period (2020-2026). The increasing demand for innovations in drug development for better
productivity in pharmaceutical production and reliable research is leading to outsourcing within the
(Get 15% Discount on Buying this Report)
A full Report of European Healthcare CDMO Market is Available
Further, the increasing expenditure in the healthcare sector by European countries has also been
observed. This is the major factor driving the growth of the European pharmaceutical contract
manufacturing industry that propels the CDMO market. Additionally, contract manufacturing and
research activities are pacing up to cater to the ever-increasing demands by the healthcare industry to
provide advanced treatment options in Europe.
Moreover, the presence of global leader biotech companies including GlaxoSmithKline PLC, Boehringer
Ingelheim GmbH, and other major biopharmaceutical companies in Europe makes it one of the leading
markets in the global life science industry. The rise in R&D investment by these market players would
significantly contribute to the growth of the European pharmaceuticals contract manufacturing market.
AstraZeneca PLC has spent a large amount of fund of around $5.6 billion for R&D during 2016-2017.
Europe has made significant R&D in pharmaceuticals mainly due to the increasing drug discovery and
research, and growing demand for innovative drugs. Additionally, the increasing investment of the